The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.13 per share. The biotechnology company posted ...
News
- Regenxbio: Q1 Earnings Snapshot
- WTO mulling intellectual property waivers for vaccines
Authors of the proposal, which has faced resistance from many countries with influential pharmaceutical and biotech industries, have been revising it ...
- Aptose Biosciences: Q1 Earnings Snapshot
Aptose Biosciences: Q1 Earnings Snapshot · 'Night in New San Antonio' event will feature rapper 50 Cent · 'It was a good first step': Coach Pop reacts to ...
- Boerne looking to seize on post-pandemic California exodus
As for the San Antonio Economic Development Foundation's regional plan, its first meeting was on May 3 in New Braunfels. Story said it was an ...
- San Antonio losing Texas race for biotech funding by wide margin
Of the more than $1.7 billion that Texas biotechnology companies raised from investors over the last six months, San Antonio's share was just over $3 ...